Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Thomas H Fischer"'
Autor:
Moritz T Huttelmaier, Sascha Münsterer, Caroline Morbach, Floran Sahiti, Nina Scholz, Judith Albert, Alexander Gabel, Christiane Angermann, Georg Ertl, Stefan Frantz, Stefan Störk, Thomas H Fischer
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0302321 (2024)
AimsThis study investigated whether an activated R-mode in patients carrying a cardiac implantable electronic device (CIED) is associated with worse prognosis during and after an episode of acutely decompensated heart failure (AHF).MethodsSix hundred
Externí odkaz:
https://doaj.org/article/ef3f8b0ac5434cbfb56a245aefc72328
Autor:
Moritz T Huttelmaier, Alexander Gabel, Maria Seewald, Carsten Jungbauer, Stefan Frantz, Stefan Störk, Thomas H Fischer
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0269816 (2022)
ObjectivesThe study aims to investigate the impact of COVID-19 pandemic on physical activity and frequency of implantable cardioverter-defibrillator (ICD) therapies of patients with cardiac implantable electronic devices.Methods and resultsPhysical a
Externí odkaz:
https://doaj.org/article/1e182b9401b14bf5b18bb930db30973a
Autor:
Leonard Bergau, Tobias Tichelbäcker, Barbora Kessel, Lars Lüthje, Thomas H Fischer, Tim Friede, Markus Zabel
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186387 (2017)
There is evidence that the benefit of a primary prophylactic ICD therapy is not equal in all patients.To evaluate risk factors of appropriate shocks and all- cause mortality in patients with a primary prophylactic ICD regarding contemporary studies.P
Externí odkaz:
https://doaj.org/article/26828f02e6834a3aaec338490016376e
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0167974 (2016)
Calcium (Ca2+) and 3',5'-cyclic adenosine monophosphate (cAMP) play a critical role for cardiac excitation-contraction-coupling. Both second messengers are known to interact with each other, for example via Ca2+-dependent modulation of phosphodiester
Externí odkaz:
https://doaj.org/article/e96e2f12833245c5aafa5a5ebf6ef4cc
Autor:
Jörg Eiringhaus, Christoph M. Wünsche, Petros Tirilomis, Jonas Herting, Nadja Bork, Viacheslav O. Nikolaev, Gerd Hasenfuss, Samuel Sossalla, Thomas H. Fischer
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2992-3002 (2020)
Abstract Aims Inhibition of neprilysin and angiotensin II receptor by sacubitril/valsartan (Val) (LCZ696) reduces mortality in heart failure (HF) patients compared with sole inhibition of renin–angiotensin system. Beneficial effects of increased na
Externí odkaz:
https://doaj.org/article/f7f7d80d8ae44c7aa85c81cb42a20f1d
Autor:
Dana N. LeVine, Rachel E. Cianciolo, Keith E. Linder, Petra Bizikova, Adam J. Birkenheuer, Marjory B. Brooks, Abdelghaffar K. Salous, Shila K. Nordone, Dwight A. Bellinger, Henry Marr, Sam L. Jones, Thomas H. Fischer, Yu Deng, Marshall Mazepa, Nigel S. Key
Publikováno v:
Platelets, Vol 30, Iss 1, Pp 88-97 (2019)
Bleeding heterogeneity amongst patients with immune thrombocytopenia (ITP) is poorly understood. Platelets play a role in maintaining endothelial integrity, and variable thrombocytopenia-induced endothelial changes may influence bleeding severity. Pl
Externí odkaz:
https://doaj.org/article/d401d13a61cd44a6aa725f1e5272a207
Publikováno v:
Die Kardiologie. 16:341-352
Autor:
Steffen Pabel, Maria Knierim, Thea Stehle, Felix Alebrand, Michael Paulus, Marcel Sieme, Melissa Herwig, Friedrich Barsch, Thomas Körtl, Arnold Pöppl, Brisca Wenner, Senka Ljubojevic-Holzer, Cristina E. Molina, Nataliya Dybkova, Daniele Camboni, Thomas H. Fischer, Simon Sedej, Daniel Scherr, Christof Schmid, Christoph Brochhausen, Gerd Hasenfuß, Lars S. Maier, Nazha Hamdani, Katrin Streckfuss-Bömeke, Samuel Sossalla
Publikováno v:
Circulation Research. 130:994-1010
Rationale: Atrial fibrillation (AF) and heart failure often coexist, but their interaction is poorly understood. Clinical data indicate that the arrhythmic component of AF may contribute to left ventricular (LV) dysfunction. Objective: This study inv
Autor:
Thomas H Fischer
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 145:526-535
The use of medical antiarrhythmic therapy apart from beta-blockers has been steadily decreasing in the recent past. This can partly be attributed to technological progress that has rendered the ablation of complex cardiac arrhythmias like atrial fibr
Publikováno v:
Clinical Cardiology
Atrial fibrillation (AF) and heart failure (HF) are epidemic cardiac diseases and are often detected in the same patient. Recent evidence suggests that this is not a mere coincidence but that the strategy of AF treatment may impact HF development. Th